Clinical trial
Methotrexate in the Treatment of Axial Spondyloarthritis
NCT00298012 · Rheumatism Foundation Hospital, Other · Withdrawn
Key facts
| NCT number | NCT00298012 |
|---|---|
| Title | Methotrexate in the Treatment of Axial Spondyloarthritis |
| Official title | Methotrexate in the Treatment of Axial Spondyloarthritis. A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study. |
| Lead sponsor | Rheumatism Foundation Hospital, Other |
| Collaborators | Orion Corporation, Orion Pharma Industry |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Spondylarthropathies, Spondylitis, Ankylosing |
| Intervention type | Drug |
| Interventions | Methotrexate |
| Enrollment | 120 |
| Start date | Mar 1, 2006 |
| First posted | Mar 1, 2006 |
| Last update posted | Jan 5, 2009 |
| Countries | Finland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: